Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New ICH Guideline Marks Turning Point In Supporting Multi-Regional Pediatric Development

Executive Summary

A new high-level draft ICH guideline issued is expected to reduce the likelihood of substantial differences among regions regarding acceptance of data generated in pediatric global drug development.

Advertisement

Related Content

ICH Expansion To Bring New Challenges For Global Consensus On Pediatric Extrapolation
Final ICH Addendum Offers Latest Perspectives On Pediatric Drug Development
Industry Sees Little Benefit Of New EU Clinical Trial Rules On Information Materials For Minors
ICH Agrees On New Extrapolation Guideline To Support Pediatric Development
EMA Explores How To Extrapolate Adult Data For Pediatric Drug Development

Topics

Advertisement
UsernamePublicRestriction

Register

PS119346

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel